Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) 96.50-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 96.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202496.50
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 96.5
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹111.3 Cr -1.5% -7.4% -10.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,780.0 Cr 2% -0.8% 39.1% Stock Analytics
KIRI INDUSTRIES ₹3,027.1 Cr -2.7% -8.7% 53.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,027.5 Cr -3.5% -3.8% -4.9% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,139.3 Cr 7.1% 10.7% 39.3% Stock Analytics
BODAL CHEMICALS ₹940.2 Cr -2.2% 2.2% -5.2% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-1.5%

-7.4%

-10.6%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses